ResMed Inc. (RMD) on Decifer

Decifer ranks RMD number 107 of 277 tracked names on durable business quality.

Why it ranks here

• It earns strong returns on the money it puts to work, around 20% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is growing about 10% a year and profits grew 38% over the past year.
• It keeps a high share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• And it returns cash to shareholders.
• Strong 20% returns and 38% profit growth with widening margins are solid, but revenue growing about 10% a year, no worldview role, and 4 out of 35 momentum keep it modest.

The current read

The evidence on RMD lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: ResMed Inc. operates in medical - devices. That places it inside the Healthcare, Biotech & Devices story.

Read the full RMD research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.